Changes in serum chitotriosidase activity with cessation of replacement enzyme (cerebrosidase) administration in Gaucher disease
- 1 March 2000
- journal article
- research article
- Published by Elsevier in Clinical Biochemistry
- Vol. 33 (2) , 147-149
- https://doi.org/10.1016/s0009-9120(99)00098-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Serum chitotriosidase activity in gaucher patients on enzyme replacement therapy (ERT)Clinical Biochemistry, 1998
- Copper and ceruloplasmin metabolism in the LEC rat, an animal model for Wilson diseaseJournal of Inherited Metabolic Disease, 1998
- 12 A practical approach to diagnosis and management of Gaucher's diseaseBailliere's Clinical Haematology, 1997
- Prospective study of neurological responses to treatment with macrophage‐targeted glucocerebrosidase in patients with type 3 Gaucher's diseaseAnnals of Neurology, 1997
- Plasma chitotriosidase activity in Gaucher disease patients who have been treated either by bone marrow transplantation or by enzyme replacement therapy with algluceraseJournal of Inherited Metabolic Disease, 1997
- Therapeutic delivery of proteins to macrophages: implications for treatment of Gaucher's diseaseThe Lancet, 1996
- Types I and III Gaucher Disease in Poland: Incidence of the Most Common Mutations and Phenotypic ManifestationsPublished by Springer Nature ,1996
- Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease.Journal of Clinical Investigation, 1994
- Replacement Therapy for Inherited Enzyme Deficiency — Macrophage-Targeted Glucocerebrosidase for Gaucher's DiseaseNew England Journal of Medicine, 1991